课题基金 / 基金详情

Ligands to study the glutamate receptor and transporters

Ligands to study the glutamate receptor and transporters
研究谷氨酸受体和转运蛋白的配体
批准号:
7525229
负责人:
Nicholas R. Natale
金额:
$14.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2010-09-30

项目摘要

项目成果

Nicholas R. Natale的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):现要求延续区域NS038444,该项目于1999年6月开始,计划于2005年5月结束。该项目的中心目标已经取得了重大进展,本申请概述了进一步假设驱动的基于结构的药物设计研究的计划,这些研究使用我们实验室开发的异恶唑化学。1. NMDA和AMPA是谷氨酸受体的亚型,与学习、记忆有关,并受衰老的影响。我们建议进一步探索我们的催化不对称合成[文献1]的应用,以制备结合并区分这些GluR亚型的配体。2. 谷氨酸转运体在谷氨酸-谷氨酰胺循环中很重要,最近Richard Bridges博士(蒙大拿大学)和我们实验室合作的初步结构活性关系(SAR)数据表明AMPA谷氨酸受体和系统Xc-转运体之间存在区别,我们可以利用我们的合成方法来开发结合选择性。因此,建议合成配体来进一步描述这些谷氨酸结合蛋白之间的选择性。3. 完整受体和转运体构象动力学的研究将通过光谱探针的使用而变得更加容易。我们拟制备分子,对谷氨酸受体和转运体系统Xc-进行光谱研究。我们在第一个目标上取得了非常令人鼓舞的进展,在第二个目标上观察到令人兴奋的初步发现,并在我们所有的努力中提出了假设驱动的、基于分子靶标的设计。与AREA项目的特殊考虑相关的是,我们的研究小组对爱达荷大学学生参与研究产生了重大的积极影响。
英文摘要
DESCRIPTION (provided by applicant): The continuation of AREA NS038444, which began in June 1999 and is scheduled to end May 2005, is requested. Significant progress has been made towards the central goal of the program, and this application outlines plans for further hypothesis-driven structure-based drug design studies which use isoxazole chemistry developed in our labs. 1. NMDA and AMPA are sub-types of glutamate receptors which are involved with learning, memory and are affected by aging. We propose to further explore the application of our catalytic asymmetric synthesis [reference 1] to prepare ligands that bind to, and to distinguish between, these GluR subtypes. 2. The Glutamate transporters are important in the glutamate-glutamine cycle, and recent preliminary Structure Activity Relationship (SAR) data from the collaboration between Dr. Richard Bridges (University of Montana) and our lab indicates a distinction between the AMPA glutamate receptor and the system Xc- transporter, which we may be able to exploit using our synthetic methodology to develop binding selectivity. Therefore, the synthesis of ligands to further delineate selectivity between these glutamate binding proteins is proposed. 3. Study of the conformational dynamics of the intact receptor and transporter would be facilitated by access to spectroscopic probes. We propose to prepare molecules to spectroscopically study the glutamate receptor and transporter system Xc-. We have reported very encouraging progress towards the first aim, observed exciting preliminary findings for the second, and present hypothesis-driven, molecular-target-based design towards all of our endeavors. And also relevant to the special considerations for the AREA program, our research group has had a significant positive impact on the participation of University of Idaho students in research.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/jm020354w
发表时间: 2003-01
期刊: Journal of medicinal chemistry
影响因子: 7.3
作者: [G. Zamponi;S. Stotz;R. Staples;Tina M Andro;J. Nelson;V. Hulubei;A. Blumenfeld;N. R. Natale]
通讯作者: G. Zamponi;S. Stotz;R. Staples;Tina M Andro;J. Nelson;V. Hulubei;A. Blumenfeld;N. R. Natale
Molecular Computation Core Research Facility
  • 批准号:
    10004083
  • 项目类别:
  • 资助金额:
    $9.88万
  • 财政年份:
    2011
  • 负责人:
    Nicholas R. Natale
  • 依托单位:
RECRUIT #2: ISOXAZOLES IN MEDICINAL CHEMISTRY
  • 批准号:
    7959451
  • 项目类别:
  • 资助金额:
    $6.42万
  • 财政年份:
    2009
  • 负责人:
    Nicholas R. Natale
  • 依托单位:
ISOXAZOLES IN MEDICINAL CHEMISTRY
  • 批准号:
    7720409
  • 项目类别:
  • 资助金额:
    $15.9万
  • 财政年份:
    2008
  • 负责人:
    Nicholas R. Natale
  • 依托单位:
ISOXAZOLES IN MEDICINAL CHEMISTRY
  • 批准号:
    7609808
  • 项目类别:
  • 资助金额:
    $19.47万
  • 财政年份:
    2007
  • 负责人:
    Nicholas R. Natale
  • 依托单位:
海外基金